DIVI'S LABORATORIES LTD. - Updates

We had earlier informed the Exchanges that the company's Unit-II at Visakhapatnam was inspected by US-FDA in September, 2017 wherein a Form-483 was issued with 6 observations.<BR> <BR> In this regard, we wish to inform you that we have now received an Establishment Inspection Report (EIR) from US-FDA for our Unit-II, as closure of audit by FDA.<BR>